Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GRI Bio Inc.
DescriptionInhibitor of type I natural killer T cells cells
Molecular Target Natural killer T cells
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLiver failure
Indication DetailsTreat acute liver failure
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today